Literature DB >> 28991665

Spinal cord anteroposterior atrophy in HAM/TSP: Magnetic resonance imaging and neuropathological analyses.

Akitoshi Taniguchi1, Hitoshi Mochizuki2, Atsushi Yamashita3, Kazutaka Shiomi1, Yujiro Asada3, Masamitsu Nakazato1.   

Abstract

To evaluate the spinal cord atrophy that occurs in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), we conducted magnetic resonance imaging (MRI) and pathological analyses. In the MRI study, 15 patients with HAM/TSP and 20 age-matched normal control subjects were enrolled. Anteroposterior and transverse distances and cross-sectional areas were measured and calculated at the C2, C4, C6, T2, and T6 vertebral levels. In the pathological study, spinal cord autopsy specimens were compared between a HAM/TSP case and an adult T cell leukemia/lymphoma case. In both the MRI and pathological studies, HAM/TSP spinal cords demonstrated more severe atrophy in the anteroposterior direction than those of controls. The spinal cord atrophy and pathological changes in HAM/TSP occurred predominantly in the white matter, especially in the lateral columns. This is the first report indicating spinal cord atrophy in the anteroposterior direction using MRI. In pathological analysis, atrophy and pathological changes were prominent in areas of the spinal cord with slow blood flow. Hemodynamic and anatomical factors are speculated to be among the main mechanisms of atrophy in the anteroposterior direction.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HTLV-1–associated myelopathy; Human T-lymphotropic virus type 1; Magnetic resonance imaging; Spinal cord atrophy; Tropical spastic paraparesis

Mesh:

Substances:

Year:  2017        PMID: 28991665     DOI: 10.1016/j.jns.2017.08.3243

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

Review 1.  Cerebral and spinal cord changes observed through magnetic resonance imaging in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis: a systematic review.

Authors:  Ana Patrícia Bastos Ferreira; Ana Dolores Firmino Santos do Nascimento; Pedro Augusto Sampaio Rocha-Filho
Journal:  J Neurovirol       Date:  2022-01-03       Impact factor: 2.643

2.  Spasticity distribution and severity in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Matheus Sales; Giselle Bárbara de Almeida Scaldaferri; Juliana Iris Barbosa Dos Santos; Ailton Melo; Nildo Manoel da Silva Ribeiro
Journal:  J Neurovirol       Date:  2020-10-06       Impact factor: 2.643

Review 3.  Antiviral Effects of Oleandrin.

Authors:  Robert A Newman; K Jagannadha Sastry; Ravit Arav-Boger; Hongyi Cai; Rick Matos; Robert Harrod
Journal:  J Exp Pharmacol       Date:  2020-11-16

4. 

Authors:  Sheila N F Liberato de Matos; Giovanna Ladeia-Rocha; José Abraão Carneiro Neto; Cassius J V de Oliveira; César Araújo Neto; Lúcia Passos; Jamary Oliveira-Filho; Edgar M Carvalho
Journal:  Ann Clin Transl Neurol       Date:  2022-03-09       Impact factor: 4.511

5.  Ocular vestibular evoked myogenic potential (VEMP) reveals mesencephalic HTLV-1-associated neurological disease.

Authors:  Tatiana Rocha Silva; Ludimila Labanca; Júlia Fonseca de Morais Caporali; Marco Aurélio Rocha Santos; Luciana Macedo de Resende; Rafael Teixeira Scoralick Dias; Denise Utsch Gonçalves
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.